Adjuvant chemotherapy dose delivery for completely resected NSCLC in a regional cancer centre: analysis of outcomes by age and comorbidity

被引：0
|
作者：
Wood, S. [1 ]
Li, R. [1 ]
Beesley, S. [1 ]
Brown, J. [1 ]
Cominos, M. [1 ]
Hall, J. [1 ]
Sevitt, T. [1 ]
Shah, R. [1 ]
Taylor, H. [1 ]
Burcombe, R. [1 ]
机构：
[1] Maidstone Hlth Author, Oncol, Maidstone, Kent, England
来源：
LUNG CANCER | 2015年 / 87卷
关键词：
D O I：
10.1016/S0169-5002(15)50065-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
66
引用
收藏
页码：S26 / S26
页数：1
相关论文
共 50 条
  • [41] Biomarker analysis from completely resected NSCLC patients enrolled in an adjuvant erlotinib clinical trial (RADIANT)
    Richardson, F.
    Richardson, K.
    Sennello, G.
    Young, D.
    Orlov, S.
    Papai-Szekely, Z.
    Keshavjee, S.
    Kim, J.
    Cerfolio, R.
    Shepherd, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [42] A FEASIBILITY STUDY OF SPLIT-DOSE CISPLATIN AND VINORELBINE AS ADJUVANT CHEMOTHERAPY FOR COMPLETELY RESECTED NON-SMALL CELL LUNG CANCER
    Hirai, Fumihiko
    Toyozawa, Ryou
    Inamasu, Eiko
    Kojo, Miyako
    Toyokawa, Gouji
    Shiraishi, Yoshimasa
    Morodomi, Yosuke
    Takenaka, Tomoyoshi
    Yamaguchi, Masafumi
    Seto, Takashi
    Takenoyama, Mitsuhiro
    Ichinose, Yukito
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S483 - S483
  • [43] Feasibility study of adjuvant chemotherapy with gemcitabine and split-dose cisplatin for completely resected non-small-cell lung cancer
    Funai, Kazuhito
    Takamochi, Kazuya
    Itaya, Toru
    Mochizuki, Takahiro
    Nakamura, Toru
    Toyoda, Futoru
    Yong-Il, Kim
    Sasaki, Kazuyoshi
    Momiki, Shigeru
    Takahashi, Tsuyoshi
    Neyatani, Hiroshi
    Suzuki, Kazuya
    LUNG CANCER, 2010, 68 (01) : 78 - 83
  • [44] Impact of hemoglobin (Hb) on outcomes of adjuvant chemotherapy (ACT) with cisplatin/vinorelbine in patients (pts) with completely resected non-small cell lung cancer (NSCLC) in JBR.10.
    Gauthier, I
    Ding, K
    Winton, T
    Shepherd, F
    Livingston, R
    Johnson, DH
    Rigas, JR
    Whitehead, M
    Graham, B
    Seymour, L
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 670S - 670S
  • [45] The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: A multicenter retrospective analysis
    Lakkunarajah, Suganija
    Breadner, Daniel Adam
    Zhang, Hanbo
    Spratlin, Jennifer L.
    Mulder, Karen E.
    Gill, Sharlene
    Sha, Aaron
    Abadi, Shirin
    Kong, Shiying
    Cheung, Winson Y.
    Loree, Jonathan M.
    Welch, Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [46] The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: a multicentered retrospective analysis
    Daniel Breadner
    Jonathan M. Loree
    Winson Y. Cheung
    Meghan Gipson
    Suganija Lakkunarajah
    Karen E. Mulder
    Jennifer L. Spartlin
    Shiying Kong
    Philip Q. Ding
    Sharlene Gill
    Stephen A. Welch
    BMC Cancer, 22
  • [47] The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: a multicentered retrospective analysis
    Breadner, Daniel
    Loree, Jonathan M.
    Cheung, Winson Y.
    Gipson, Meghan
    Lakkunarajah, Suganija
    Mulder, Karen E.
    Spartlin, Jennifer L.
    Kong, Shiying
    Ding, Philip Q.
    Gill, Sharlene
    Welch, Stephen A.
    BMC CANCER, 2022, 22 (01)
  • [48] Outcomes of patients undergoing adjuvant platinum-vinorelbine chemotherapy for resected non-small cell lung cancer (NSCLC)
    Pender, A.
    Coward, J.
    Gunapala, R.
    Bhosle, J.
    O'Brien, M.
    Popat, S.
    LUNG CANCER, 2013, 79 : S12 - S12
  • [49] OUTCOMES OF PATIENTS UNDERGOING ADJUVANT PLATINUM- VINORELBINE CHEMOTHERAPY FOR RESECTED NON- SMALL CELL LUNG CANCER (NSCLC)
    Pender, Alexandra
    Coward, Jim
    Gunapala, Ranga
    Brien, Mary O.
    Bhosle, Jaishree
    Popat, Sanjay
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1168 - S1168
  • [50] Patient outcome following adjuvant chemotherapy (CT) in completely resected, stage I-IIIB, non-small cell lung cancer (NSCLC)
    Dediu, M.
    Horvat, T.
    Anghel, R.
    Tarlea, A.
    Alexandru, A.
    Median, D.
    Nistor, C.
    Savu, C.
    Ciuche, A.
    Iorga, P.
    LUNG CANCER, 2006, 52 : S20 - S21
12345